Evidence map›Paper›PMID 31106262›Full record

ArticleACS biomaterials science & engineering2018

A chemical treatment method for obtaining clean and intact pollen shells of different species.

Pedro Gonzalez-Cruz, Md Jasim Uddin, Shashwati U Atwe, Noureddine Abidi, Harvinder Singh Gill

Abstract read
In one paragraph

Article in ACS biomaterials science & engineering, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 72 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. ACS omega · 2020
    Article
  18. Actuation and locomotion driven by moisture in paper made with natural pollen.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  19. Pollen grains as a novel microcarrier for oral delivery of proteins.International journal of pharmaceutics · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Pedro Gonzalez-CruzDepartment of Chemical Engineering, Texas Tech University, Lubbock, TX 79409, USA.
Md Jasim UddinDepartment of Chemical Engineering, Texas Tech University, Lubbock, TX 79409, USA.
Shashwati U AtweDepartment of Chemical Engineering, Texas Tech University, Lubbock, TX 79409, USA.
Noureddine AbidiDepartment of Plant and Soil Science, Texas Tech University, Lubbock, TX 79409, USA.
Harvinder Singh GillDepartment of Chemical Engineering, Texas Tech University, Lubbock, TX 79409, USA.
Texas Tech University · US

Funding

POLLEN GRAINS AS TROJAN HORSES FOR ORAL VACCINATIONDP2HD075691 · NICHD · TEXAS TECH UNIVERSITY · PI GILL, HARVINDER SINGH · 2012 to 2012
$2.2M
NICHD NIH HHS DP2 HD075691
6 · The paper itself

Abstract

Pollen grains and plant spores have emerged as a novel biomaterial for a broad range of applications including oral drug and vaccine delivery, catalyst support, and removal of heavy metals. However, before pollens can be used, their intrinsic biomolecules, which occupy a large part of the pollen inner cavity must be removed not only to create empty space but because they have potential to cause allergies when used in vivo. These intrinsic materials in the pollen core can be extracted through a chemical treatment to generate clean pollen shells. The commonly used method involves a series of sequential treatments with organic solvents, alkalis, and acids to remove the native pollen biomolecules. This method, though successful for treating lycopodium (

Indexed as

Pollen aperturePollen treatmentPollen turgor pressureRagweed pollenSporopollenin

Identifiers

PMID31106262
PMCPMC6516503
OpenAlexW2805180797

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.